5PSQ-030 Use of cefiderocol for multidrug-resistant Acinetobacter baumannii in patients with SARS-CoV-2: two case reports

Background and importanceCefiderocol is a new siderophore cephalosporin for the treatment of multidrug-resistant Gram-negative pathogens such as Acinetobacter baumannii (AB).Aim and objectivesTo describe our clinical experience with cefiderocol use in two SARS-CoV-2 patients with ventilator-associat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2022-03, Vol.29 (Suppl 1), p.A127-A128
Hauptverfasser:	Briceño Casado, MDP, Criado-Rubio, B, Gil-Sierra, MD, De La Calle-Riaguas, B, Garcia-Esteban, B
Format:	Artikel
Sprache:	eng
Schlagworte:	Case reports Conflicts of interest Drug resistance Hypertension Multidrug resistant organisms Patients Section 5: Patient safety and quality assurance Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!